Skip to main content
Topical Ruxolitinib Effective for AD in Study of Children Ages 2-11 years
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Topical Ruxolitinib Effective for AD in Study of Children Ages 2-11 years
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Child
0
0.99
Atopic Dermatitis
0
0.98
Clinical Research
0
0.23
Healthcare and Medical Technology
0
0.2
Eczema
0
0.12
Folliculitis
0
0.12
Myelosuppression
0
0.12
Paresthesia
0
0.12
Plasma
0
0.12
Quality of Life
0
0.12
Skin and Soft Tissue Infection
0
0.1
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.9
Pediatrics
0
0.8
Edit Tags